NYSE · Medical - Healthcare Plans

UnitedHealth Group Incorporated Common Stock (DE) (UNH) Stock

$370.95 -1.34% NYSE: UNH Healthcare

Valuation

MetricValue
Price$370.95
Market Cap$336.88B
P/E Ratio24.22
P/B Ratio3.47
P/S Ratio0.76
EPS (TTM)$13.23
52-Week High$461.62
52-Week Low$255.97
Dividend Yield2.46%

Financials & Margins

MetricValue
ROE14.63%
ROA4.56%
ROCE10.95%
Gross Margin18.80%
Operating Margin4.19%
Net Margin3.14%
Debt/Equity0.74
Current Ratio0.80

Annual Financials (USD)

Metric20212022202320242025
Revenue$287.6B$324.2B$371.6B$400.3B$447.6B
Operating Profit$24.0B$28.4B$32.4B$32.3B$19.0B
Net Profit$17.3B$20.1B$22.4B$14.4B$12.1B
EPS$18.08$21.18$23.86$15.51$13.23
Op Margin8.3%8.8%8.7%8.1%4.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$212.2B$245.7B$273.7B$298.3B$309.6B
Total Liabilities$135.7B$159.4B$174.8B$195.7B$207.9B
Cash$21.4B$23.4B$25.4B$25.3B$24.4B
Borrowings$46.0B$57.6B$67.4B$76.9B$78.4B

Latest News

UnitedHealth’s Stock Run Is Strong. Earnings Will Gauge Medicare Advantage Recovery. Barrons.com · Jul 15, 2026 Piper Sandler Raises Price Target on UnitedHealth Group to $475 From $420, Maintains Overweight Rating MT Newswires · Jul 15, 2026 Elevance Beat Earnings Estimates, but the Stock Falls on Medicaid Spending Worries Barrons.com · Jul 15, 2026 ELV Beats Q2 Earnings Estimates on Higher CarelonRx Product Revenues Zacks · Jul 15, 2026 Will UnitedHealth (UNH) Beat Estimates Again in Its Next Earnings Report? Zacks · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$22.3B$26.2B$29.1B$24.2B$19.7B
Investing Cash Flow$-12.8B$-31.3B$-19.0B$-24.0B$-12.3B
Financing Cash Flow$-4.7B$-3.6B$-10.4B$-12.5B$-4.5B
Net Cash Flow$4.5B$2.0B$2.1B$-115.0M$2.8B
Free Cash Flow$19.9B$23.4B$25.7B$20.7B$16.1B

Valuation & Return Ratios

MetricValue
PEG Ratio-0.73
EV / EBITDA15.01
FCF Yield6.91%
Quick Ratio0.78
Interest Coverage5.57
Return 1Y7.68%
Return 3Y-23.64%
Return 5Y1.78%

Ownership

Insiders Held0.24%
Institutions Held85.85%
Institutions Float Held86.05%
Institutional HolderSharesReport Date
Blackrock Inc.73,467,5312026-03-31
Vanguard Capital Management LLC58,870,7772026-03-31
State Street Corporation45,332,1862026-03-31
Capital World Investors27,783,4152026-03-31
Vanguard Portfolio Management LLC24,036,5042026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALHCAlignment Healthcare, Inc. $8.71 +1.87% 41.70 $1.81B 0.00%
CIThe Cigna Group $281.03 +0.90% 11.22 $74.26B 2.29%
CNCCentene Corporation $64.54 -0.69% -6.18 $31.88B 0.00%
CVSCVS Health Corporation $87.80 -0.17% 23.27 $112.03B 2.98%
ELVElevance Health, Inc. $400.94 -0.83% 17.60 $86.95B 1.74%

About UnitedHealth Group Incorporated Common Stock (DE)

UnitedHealth Group Incorporated Common Stock (DE) is led by CEO Stephen J. Hemsley, employs 400,000 people, headquartered in Eden Prairie, US, publicly traded since 1984.

UnitedHealth Group Incorporated Common Stock (DE) (UNH) stock trades at $370.95 with a market capitalization of $336.88B. The stock is valued at a price-to-earnings (P/E) ratio of 24.22, price-to-book of 3.47, price-to-sales of 0.76. Over the past 52 weeks the stock has ranged between $255.97 and $461.62, and currently trades 19.6% below its 52-week high. It pays a dividend yielding 2.46%.

On profitability, UnitedHealth Group Incorporated Common Stock (DE) generates a return on equity (ROE) of 14.63%, above the typical market average, return on capital employed of 10.95%, an operating margin of 4.19%, a net profit margin of 3.14%.

In its most recent fiscal year, UnitedHealth Group Incorporated Common Stock (DE) reported annual revenue of $447.6B, net profit of $12.1B, revenue has compounded at 11.7% a year over the last five years, profit at -4.8% a year.

The balance sheet shows a debt-to-equity ratio of 0.74, a current ratio of 0.80, total assets of $309.6B, $24.4B in cash and equivalents.

UNH has a beta of 0.62 (less volatile than the overall market).

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21% PFE Pfizer, Inc. $27.82 -0.64%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides